Isolated cutaneous Langerhans cell histiocytosis in a premature baby: What is the optimal approach?
Heidrun Herbrüggen MD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorKaroly Lakatos MD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorHelmut Gadner MD, FRCP
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorCorresponding Author
Milen Minkov MD, PhD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Associate Professor of Pediatrics Head, Department Outpatient Hematology/Oncology, St. Anna Children's Hospital, Medical University of Vienna, Kinderspitalgasse 6, A-1090 Vienna, Austria.===Search for more papers by this authorHeidrun Herbrüggen MD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorKaroly Lakatos MD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorHelmut Gadner MD, FRCP
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorCorresponding Author
Milen Minkov MD, PhD
St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Associate Professor of Pediatrics Head, Department Outpatient Hematology/Oncology, St. Anna Children's Hospital, Medical University of Vienna, Kinderspitalgasse 6, A-1090 Vienna, Austria.===Search for more papers by this author
REFERENCES
- 1
Komp DM,
Herson J,
Starling KA, et al.
A staging system for histiocytosis X: A Southwest Oncology Group Study.
Cancer
1981;
47:
798–800.
10.1002/1097-0142(19810215)47:4<798::AID-CNCR2820470427>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- 2 Lahey ME. Prognostic factors in histiocytosis X. Am J Pediatr Hematol Oncol 1981; 3: 57–60.
- 3 Gadner H, Grois N, Potschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2008; 111: 2556–2562.
- 4 Ronceray L, Potschger U, Janka G, et al. Pulmonary Involvement in pediatric-onset multisystem langerhans cell histiocytosis: Effect on course and outcome. J Pediatr 2012; 161: 129–133.
- 5 Aviner S, Ronen M, London D, et al. Langerhans cell histiocytosis in a premature baby presenting with skin-isolated disease: Case report and literature review. Acta Paediatr 2008; 97: 1751–1754.
- 6 Minkov M, Prosch H, Steiner M, et al. Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer 2005; 45: 802–807.
- 7 Broadbent V, Gadner H, Komp DM, et al. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol 1989; 17: 492–495.
- 8 Bove KE, Hurtubise P, Wong KY. Thymus in untreated systemic histiocytosis X. Pediatr Pathol 1985; 4: 99–115.
- 9 Hamoudi AB, Newton WA, Jr., Mancer K, et al. Thymic changes in histiocytosis. Am J Clin Pathol 1982; 77: 169–173.
